Skip to main content

Table 1 USPSTF cancer screening eligibility criteria and intervals

From: Emergency department-based cancer screening interventions

Cancer

Patient populationa

Screening test(s)

Recommended screening interval(s)

Breast

Women age 50–74 years

Screening mammogram

Every 2 years

Cervical

Women age 21–65 years

Papanicolaou (Pap) test

High-risk human papillomavirus (hrHPV) test

Pap and hrHPV tests (co-testing)

Every 3 years

Every 5 years (age 30–65 only)

Every 5 years (age 30–65 only)

Colorectal

Age 45–75 years

Colonoscopy

Sigmoidoscopy

Fecal occult blood tests

Fecal immunochemical tests

CT colonography

Stool DNA tests (e.g., Cologuard)

Every 10 years

Every 5 years

Annually

Annually

Every 5 years

Every 1 to 3 years

Lung

Age 50–80 years with a 20 pack-year smoking history and have smoked within the past 15 years

Low-dose computed tomography (CT) of the chest

Annually (until the individual has not smoked within 15 years)

  1. aPatient population refers to those individuals for whom the USPSTF has provided an A- or B-level recommendation for screening. Other patient sub-populations, based on personal and family history, can also benefit from screenings